Impact of the Niemann-Pick c1 Gene Mutation on the Total Cellular Glycomics of CHO Cells

被引:9
|
作者
Furukawa, Jun-ichi [1 ,4 ,5 ]
Soga, Minami [3 ]
Okada, Kazue [1 ,4 ,5 ]
Yokota, Ikuko [1 ,4 ,5 ]
Piao, Jinhua [1 ]
Irie, Tetsumi [3 ]
Era, Takumi [2 ]
Shinohara, Yasuro [1 ,6 ]
机构
[1] Hokkaido Univ, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan
[2] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto 8600811, Japan
[3] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Kumamoto 8620973, Japan
[4] Hokkaido Univ, Fac Med, Dept Adv Clin Glycobiol, Sapporo, Hokkaido 0010021, Japan
[5] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0010021, Japan
[6] Kinjo Gakuin Univ, Dept Pharm, Nagoya, Aichi 4638521, Japan
关键词
Niemann-Pick disease; glycomics; N-glycan; O-glycan; glycosaminoglycan; glycosphingolipids; free oligosaccharide; cyclodextrin; DISEASE TYPE-C; N-GLYCOSYLATION; HEPARAN-SULFATE; STORAGE; IDENTIFICATION; ACCUMULATION; BIOMARKERS; MIGLUSTAT; TRANSPORT; CERAMIDE;
D O I
10.1021/acs.jproteome.7b00070
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Niemann-Pick disease type C (NPC) is an autosomal recessive lipid storage disorder, and the majority of cases are caused by mutations in the NPC1 gene. In this study, we clarified how a single gene mutation in the NPC1 gene impacts the cellular glycome by analyzing the total glycomic expression profile of Chinese hamster ovary cell mutants defective in the Npc1 gene (Npc1 KO CHO cells). A number of glycomic alterations were identified, including increased expression of lactosylceramide, GM1, GM2, GD1, various neolacto-series glycosphingolipids, and sialyl-T (O-glycan), which was found to be the major sialylated protein-bound glycan, as well as various N-glycans, which were commonly both fucosylated and sialylated. We also observed significant increases in the total amounts of free oligosaccharides (fOSs), especially in the unique complex- and hybrid-type fOSs. Treatment of Npc1 KO CHO cells with 2-hydroxypropyl-beta-cyclodextrin (HPBCD), which can reduce cholesterol and glycosphingolipid (GSL) storage, did not affect the glycomic alterations observed in the GSL-, N-, and O-glycans of Npc1 KO CHO cells. However, HPBCD treatment corrected the glycomic alterations observed in fOSs to levels observed in wild-type cells.
引用
收藏
页码:2802 / 2810
页数:9
相关论文
共 50 条
  • [41] Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression
    Baxter, Laura L.
    Watkins-Chow, Dawn E.
    Johnson, Nicholas L.
    Farhat, Nicole Y.
    Platt, Frances M.
    Dale, Ryan K.
    Porter, Forbes D.
    Pavan, William J.
    Rodriguez-Gil, Jorge L.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years
    Moreno, Pilar Guatibonza
    Pardo, Luba M. M.
    Pereira, Catarina
    Schroeder, Sabine
    Vagiri, Deepthi
    Almeida, Ligia S. S.
    Juaristi, Carlos
    Hosny, Heba
    Loh, Clarice C. Y.
    Leubauer, Anika
    Morales, Galina Torres
    Oppermann, Sebastian
    Iurascu, Marius-Ionut
    Fischer, Steffen
    Steinicke, Tara-Marisa
    Viceconte, Nikenza
    Cozma, Claudia
    Kandaswamy, Krishna Kumar
    Basto, Jorge Pinto
    Boettcher, Tobias
    Bauer, Peter
    Bertoli-Avella, Aida
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (10) : 1108 - 1116
  • [43] Precision Medicine in Cats: Novel Niemann-Pick Type C1 Diagnosed by Whole-Genome Sequencing
    Mauler, D. A.
    Gandolfi, B.
    Reinero, C. R.
    O'Brien, D. P.
    Spooner, J. L.
    Lyons, L. A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (02): : 539 - 544
  • [44] Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection
    Cote, Marceline
    Misasi, John
    Ren, Tao
    Bruchez, Anna
    Lee, Kyungae
    Filone, Claire Marie
    Hensley, Lisa
    Li, Qi
    Ory, Daniel
    Chandran, Kartik
    Cunningham, James
    NATURE, 2011, 477 (7364) : 344 - U122
  • [45] Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1
    Cougnoux, Antony
    Yerger, Julia C.
    Fellmeth, Mason
    Serra-Vinardell, Jenny
    Navid, Fatemeh
    Wassif, Christopher A.
    Cawley, Niamh X.
    Porter, Forbes D.
    MOLECULAR GENETICS AND METABOLISM, 2021, 134 (04) : 330 - 336
  • [46] Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteria
    Weng, Yuzhe
    Shepherd, Dawn
    Liu, Yi
    Krishnan, Nitya
    Robertson, Brian D.
    Platt, Nick
    Larrouy-Maumus, Gerald
    Platt, Frances M.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] Therapeutic potential of histone deacetylase inhibitor for treatment of Niemann-Pick type C1 disease
    Nina H Pipalia
    Frederick R Maxfield
    Molecular Cytogenetics, 7 (Suppl 1)
  • [48] Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots
    Jiang, Xuntian
    Sidhu, Rohini
    Orsini, Joseph J.
    Farhat, Nicole Y.
    Porter, Forbes D.
    Berry-Kravis, Elizabeth
    Schaffer, Jean E.
    Ory, Daniel S.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : 183 - 187
  • [49] The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes
    Garver, William S.
    Jelinek, David
    Meaney, F. John
    Flynn, James
    Pettit, Kathleen M.
    Shepherd, Glen
    Heidenreich, Randall A.
    Vockley, Cate M. Walsh
    Castro, Graciela
    Francis, Gordon A.
    JOURNAL OF LIPID RESEARCH, 2010, 51 (02) : 406 - 415
  • [50] Niemann-Pick Type C1 deficiency in microglia does not cause neuron death in vitro
    Peake, Kyle B.
    Campenot, Robert B.
    Vance, Dennis E.
    Vance, Jean E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (09): : 1121 - 1129